Tehran University of Medical Sciences

Science Communicator Platform

Stay connected! Follow us on X network (Twitter):
Share By
Chitosan Nanoparticles Improve the Effectivity of Miltefosine Against Acanthamoeba Publisher Pubmed



Latifi A1 ; Esmaeili F2 ; Mohebali M1, 3 ; Yasamikhiabani S4 ; Rezaeian M1 ; Soleimani M5 ; Kazemirad E1 ; Amani A6
Authors

Source: PLoS Neglected Tropical Diseases Published:2024


Abstract

Background Acanthamoeba keratitis (AK) is a corneal sight-threatening infection caused by the free-living amoebae of the genus Acanthamoeba. Early and appropriate treatment significantly impacts visual outcomes. Mucoadhesive polymers such as chitosan are a potential strategy to prolong the residence time and bioavailability of the encapsulated drugs in the cornea. Regarding the recent administration of miltefosine (MF) for treating resistant AK, in the present study, we synthesized miltefosine-loaded chitosan nanoparticles (MF-CS-NPs) and evaluated them against Acanthamoeba. Methodology/Principal findings Chitosan nanoparticles (CNPs) were prepared using the ionic gelation method with negatively charged tripolyphosphate (TPP). The zeta-potential (ZP) and the particle size of MFCS-NPs were 21.8±3.2 mV and 46.61±18.16 nm, respectively. The release profile of MFCS-NPs indicated linearity with sustained drug release. The cytotoxicity of MF-CS-NPs on the Vero cell line was 2.67 and 1.64 times lower than free MF at 24 and 48 hours. This formulation exhibited no hemolytic activity in vitro and ocular irritation in rabbit eyes. The IC50 of MF-CS-NPs showed a significant reduction by 2.06 and 1.69-fold in trophozoites at 24 and 48 hours compared to free MF. Also, the MF-CS-NPs IC50 in the cysts form was slightly decreased by 1.26 and 1.21-fold at 24 and 48 hours compared to free MF. Conclusions The MF-CS-NPs were more effective against the trophozoites and cysts than free MF. The nano-chitosan formulation was more effective on trophozoites than the cysts form. MF-CSNPs reduced toxicity and improved the amoebicidal effect of MF. Nano-chitosan could be an ideal carrier that decreases the cytotoxicity of miltefosine. Further analysis in animal settings is needed to evaluate this nano-formulation for clinical ocular drug delivery. © 2024 Latifi et al.
Related Docs
View other Related Docs
1. Comparing Cytotoxicity and Efficacy of Miltefosine and Standard Antimicrobial Agents Against Acanthamoeba Trophozoites and Cyst Forms: An in Vitro Study, Acta Tropica (2023)
2. A Review Study About the Effect of Chitosan Nanocarrier on Improving the Efficacy of Amphotericin B in the Treatment of Leishmania From 2010 to 2020, Current Drug Delivery (2021)
3. Prospects and Challenges of Anticancer Agents’ Delivery Via Chitosan-Based Drug Carriers to Combat Breast Cancer: A Review, Carbohydrate Polymers (2021)
Experts (# of related papers)
View all Related Experts
Mahdi Mohebali (3)
Rassoul Dinarvand (3)
Other Related Docs
4. A Review of Chitosan Role in Milk Bioactive-Based Drug Delivery, Smart Packaging and Biosensors: Recent Advances and Developments, International Journal of Biological Macromolecules (2025)
5. Ocular Implant Containing Bevacizumab-Loaded Chitosan Nanoparticles Intended for Choroidal Neovascularization Treatment, Journal of Biomedical Materials Research - Part A (2018)
6. Enhanced Antibacterial Activity of Porous Chitosan-Based Hydrogels Crosslinked With Gelatin and Metal Ions, Scientific Reports (2024)
7. Anti-Acanthamoeba Effects of Silver and Gold Nanoparticles and Contact Lenses Disinfection Solutions, Iranian Journal of Parasitology (2018)
8. Biocompatibility Improvement of Artificial Cornea Using Chitosan-Dextran Nanoparticles Containing Bioactive Macromolecules Obtained From Human Amniotic Membrane, International Journal of Biological Macromolecules (2021)
9. Evaluation of Antimicrobial Activity of Thiolated Methylated N-(4-N,N-Dimethylaminobenzyl) Chitosan As a New Derivative of Chitosan, Letters in Applied Microbiology (2022)
10. Amoxicillin-Docosahexaenoic Acid Encapsulated Chitosan-Alginate Nanoparticles As a Delivery System With Enhanced Biocidal Activities Against Helicobacter Pylori and Improved Ulcer Healing, Frontiers in Microbiology (2023)
11. Methylated 4-N,N Dimethyl Aminobenzyl N,O Carboxymethyl Chitosan As a New Chitosan Derivative: Synthesis, Characterization, Cytotoxicity and Antibacterial Activity, Carbohydrate Polymers (2016)
12. Biomacromolecule Chitosan Carrying Meglumine Antimoniate Coated on a Silver/Polyurethane Nanocomposite As a Wound Dressing: Therapeutic Efficacy on Cutaneous Leishmaniasis Caused by Leishmania Major in Balb/C Mice, International Journal of Biological Macromolecules (2025)
13. Antibacterial and Anti-Biofilm Activities of Silver Nano Particles Conjugated to Chitosan Against Multi-Drug Resistant Bacteria, Clinical Laboratory (2023)
14. Biguanidylated Chitosan Nanofiber Scaffold: A Green Approach to Promote Osteogenesis in Calvarial Bone Regeneration, Carbohydrate Polymers (2025)
15. Effective Antibacterial Electrospun Cellulose Acetate Nanofibrous Patches Containing Chitosan/Erythromycin Nanoparticles, International Journal of Biological Macromolecules (2021)
16. Chitosan Crosslinkers and Their Functionality in 3D Bioprinting to Produce Chitosan-Based Bioinks, Inorganic Chemistry Communications (2024)
17. Polyhexamethylene Biguanidine Coated Silver Nanoparticles Embedded Into Chitosan Thiourea/Pva Nanofibers As Wound Healing Mats: In Vitro and in Vivo Studies, Carbohydrate Polymers (2025)
18. Tripolyphosphate-Crosslinked Chitosan/Poly (Ethylene Oxide) Electrospun Nanofibrous Mats As a Floating Gastro-Retentive Delivery System for Ranitidine Hydrochloride, Journal of Pharmaceutical and Biomedical Analysis (2018)
19. Preparation of Ph-Sensitive Chitosan/Polyvinylpyrrolidone/Α-Fe2o3 Nanocomposite for Drug Delivery Application: Emphasis on Ameliorating Restrictions, International Journal of Biological Macromolecules (2021)
20. Curcumin-Loaded Chitosan-Agarose-Montmorillonite Hydrogel Nanocomposite for the Treatment of Breast Cancer, 27th National and 5th International Iranian Conference of Biomedical Engineering# ICBME 2020 (2020)